ACH Accendra Health, Inc. Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Gen 24, 2024ACH Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
ACH Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 01 Aprile 2010 | 3-for-2 | Avanti |
| 09 Giugno 1994 | 3-for-2 | Avanti |
| 23 Marzo 1993 | 3-for-2 | Avanti |
| 17 Luglio 1991 | 3-for-2 | Avanti |
| 01 Giugno 1988 | 3-for-2 | Avanti |
| 03 Settembre 1985 | 3-for-2 | Avanti |
| 01 Novembre 1982 | 2-for-1 | Avanti |
Informazioni su Accendra Health, Inc. Common Stock Panoramica della società da Wikipedia
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.
History
Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.
In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.
By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.
In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.
In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.
In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.
Personnel
On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.
Richmond, Virginia center
In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.
Movianto
In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.
Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.
In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.
On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.
Divest of P&HS - Rebrand Accendra Health, Inc.
On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Dic 14, 2021 | $0,00 | USD | ≈0.03% |
| Set 14, 2021 | $0,00 | USD | ≈0.03% |
| Giu 14, 2021 | $0,00 | USD | ≈0.03% |
| Mar 12, 2021 | $0,00 | USD | ≈0.03% |
| Dic 14, 2020 | $0,00 | USD | ≈0.04% |
| Set 14, 2020 | $0,00 | USD | ≈0.08% |
| Giu 12, 2020 | $0,00 | USD | ≈0.16% |
| Mar 13, 2020 | $0,00 | USD | ≈0.28% |
| Dic 13, 2019 | $0,00 | USD | ≈1.6% |
| Set 13, 2019 | $0,00 | USD | ≈5.5% |
| Giu 13, 2019 | $0,00 | USD | ≈20.8% |
| Mar 14, 2019 | $0,00 | USD | ≈12.6% |
| Dic 14, 2018 | $0,08 | USD | ≈13.2% |
| Set 14, 2018 | $0,26 | USD | ≈6.4% |
| Giu 14, 2018 | $0,26 | USD | ≈6.4% |
| Mar 14, 2018 | $0,26 | USD | ≈6.2% |
| Dic 14, 2017 | $0,26 | USD | ≈5.5% |
| Set 14, 2017 | $0,26 | USD | ≈3.6% |
| Giu 13, 2017 | $0,26 | USD | ≈3.2% |
| Mar 13, 2017 | $0,26 | USD | ≈2.9% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 10, 2026 | $-0.19 | $-0.09 | -113.0% |
| 31 Marzo 2026 | $-0.04 | $-0.10 | 60.9% | |
| 31 Dicembre 2025 | $0.21 | $0.22 | -5.8% | |
| 30 Settembre 2025 | $0.25 | $0.23 | 6.7% | |
| 30 Giugno 2025 | $0.26 | $0.28 | -6.3% | |
| 31 Marzo 2025 | $0.23 | $0.20 | 16.6% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B | $181.02B | $144.85B | |
| Cost of Revenue | $259.70B | $264.17B | $188.52B | $179.28B | $167.11B | $166.29B | $133.70B | |
| Gross Profit | $31.28B | $34.72B | $15.47B | $10.93B | $13.24B | $14.73B | $11.15B | |
| R&D Expense | $4.81B | $2.42B | $1.47B | $941M | $627M | $498M | $169M | |
| SG&A Expense | $6.01B | $6.33B | $5.06B | $3.97B | $3.98B | $4.55B | · | |
| Operating Income | $16.39B | $18.67B | $7.60B | $6.21B | $6.82B | · | · | |
| Interest Expense | $3.83B | $4.51B | $4.99B | $4.38B | $4.69B | $4.83B | $4.76B | |
| Interest Income | $477M | $311M | $266M | $261M | $492M | $707M | $816M | |
| Pretax Income | $13.21B | $14.19B | $2.89B | $1.87B | $2.27B | $3.05B | $1.62B | |
| Income Tax | $2.37B | $2.87B | $641M | $632M | $826M | $644M | $404M | |
| Net Income | $4.19B | $5.76B | $862M | $596M | $709M | $1.41B | $366M | |
| EPS (Basic) | $0.24 | $0.33 | $0.03 | $0.02 | $0.03 | $0.09 | $0.02 | |
| EPS (Diluted) | $0.24 | $0.33 | $0.03 | $0.02 | · | · | · | |
| Shares (Basic) | 17,022,673 | 17,022,673 | 17,022,673 | 17,022,673 | 16,842,714 | 14,903,798,236 | 14,903,798,236 | |
| Shares (Diluted) | · | · | · | 17,022,672,951 | 16,842,713,738 | 14,903,798,236 | 14,903,798,236 | |
| EBITDA | $16.39B | $13.41B | $6.02B | · | · | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.82B | $19.68B | $9.67B | $7.78B | $19.13B | $27.85B | $23.85B | |
| Receivables | $5.87B | $7.11B | $9.31B | $7.42B | $8.10B | · | · | |
| Inventory | $24.71B | $21.64B | $19.86B | $19.52B | $20.46B | $20.55B | $17.93B | |
| Current Assets | $54.54B | $54.11B | $46.27B | $48.70B | $58.90B | $68.64B | $66.49B | |
| PP&E (Net) | $109.28B | $121.38B | $130.93B | $103.49B | $99.61B | $95.73B | $90.37B | |
| Goodwill | $3.50B | $3.51B | $3.51B | · | · | · | · | |
| Total Assets | $212.35B | $224.86B | $195.04B | $203.14B | $200.96B | $199.82B | $190.51B | |
| Current Liabilities | $62.37B | $61.92B | $62.63B | $69.20B | $74.84B | $90.34B | $83.18B | |
| Total Liabilities | $124.59B | $135.17B | $123.74B | $132.38B | $133.30B | $134.07B | $134.72B | |
| Retained Earnings | $10.09B | $6.81B | $-1.98B | $-2.21B | $-2.86B | $-3.33B | $-4.64B | |
| Stockholders' Equity | $54.40B | $60.48B | $54.45B | $54.67B | $52.42B | $39.69B | $38.17B |
Flusso di cassa
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $8.06B | $7.06B | $7.00B | |
| Operating Cash Flow | $27.75B | $35.16B | $19.42B | $12.51B | $13.02B | $13.21B | $11.61B | |
| CapEx | $4.42B | $3.19B | $10.33B | $9.05B | $6.75B | $8.89B | $6.33B | |
| Investing Cash Flow | $-3.42B | $-1.67B | $-3.31B | $-13.40B | $-5.53B | $-5.60B | $-2.63B | |
| Dividends Paid | $2.51B | $579M | $423M | $223M | $328M | $309M | $20M | |
| Financing Cash Flow | $-27.04B | $-23.41B | $-18.23B | $-10.47B | $-16.28B | $-3.39B | $-6.11B | |
| Free Cash Flow | $23.33B | $26.19B | $9.84B | $3.58B | · | · | · | |
| Levered FCF | $20.19B | $23.50B | $7.02B | $501M | · | · | · |
Redditività
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 9.8% | 7.2% | 6.4% | · | · | · | |
| Operating Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| Net Margin | 1.4% | 1.9% | 0.40% | 0.45% | · | · | · | |
| Pretax Margin | 4.5% | 3.8% | 1.2% | 1.1% | · | · | · | |
| EBITDA Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| ROA | 1.9% | 2.6% | 0.37% | 0.42% | · | · | · | |
| ROE | 7.3% | 9.1% | 1.4% | 1.6% | · | · | · | |
| ROIC | 24.7% | 17.9% | 8.1% | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.7 | 0.7 | · | · | · | |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · | · | · | |
| Interest Coverage | 4.3 | 3.8 | 1.6 | · | · | · | · |
Efficienza
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.4 | 0.9 | 0.9 | · | · | · | |
| Inventory Turnover | 11.2 | 12.6 | 8.8 | 8.9 | · | · | · | |
| Receivables Turnover | 44.8 | 33.3 | 22.3 | 24.5 | · | · | · |
Per Azione
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | $11.17 | · | · | · | |
| Cash Flow / Share | · | · | · | $0.73 | · | · | · | |
| EPS (TTM) | $0.24 | $0.29 | $0.03 | $0.02 | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $290.99B | $269.75B | $185.99B | $190.22B | · | · | · | |
| Net Income TTM | $4.19B | $5.08B | $764M | $596M | · | · | · | |
| P/E | 81.7 | 152.1 | 901.7 | 235.0 | · | · | · | |
| Earnings Yield | 1.2% | 0.66% | 0.11% | 0.43% | · | · | · | |
| Payout Ratio | 60.0% | 9.1% | 48.1% | 26.2% | · | · | · | |
| Annual Payout | $2.51B | $461M | $356M | $223M | · | · | · |
Per Azione
| Metrica | Tendenza | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | · | $0.29 | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $269.75B | · | · | $144.85B | $123.67B | · | · | · | · | · | |
| Net Income TTM | · | $5.08B | · | · | $366M | $130M | · | · | · | · | · | |
| P/E | · | 152.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | 0.66% | · | · | · | · | · | · | · | · | · | |
| Annual Payout | · | $461M | · | · | $20M | $20M | · | · | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Ricavi | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B |
| Margine Lordo % | 10.8% | 9.8% | 7.2% | 6.4% | · |
| Margine Operativo % | 5.6% | 5.0% | 3.2% | · | · |
| Utile netto | $4.19B | $5.76B | $862M | $596M | $709M |
| EPS Diluito | $0.24 | $0.33 | $0.03 | $0.02 | · |
| Metrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 0.9 | 0.9 | 0.7 | 0.7 | · |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · |
| Metrica | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $23.33B | $26.19B | $9.84B | $3.58B | · |
Proprietari istituzionali (13F) 161 filer · $236.6M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 22 (-7 vs trimestre precedente) | 21 (-25 vs trimestre precedente) | 47 (+8 vs trimestre precedente) | 45 (-7 vs trimestre precedente) | -61K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | $44.804.760 | 13.100.807 | 18,94% | Azioni |
| BlackRock, Inc. | $18.824.028 | 5.504.102 | 7,96% | Azioni |
| VANGUARD GROUP INC | $17.691.199 | 6.318.285 | 7,48% | Azioni |
| BANK OF AMERICA CORP /DE/ | $12.912.296 | 3.775.525 | 5,46% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.560.724 | 3.087.931 | 4,46% | Azioni |
| D. E. Shaw & Co., Inc. | $10.538.412 | 3.081.407 | 4,45% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.877.158 | 2.888.058 | 4,17% | Azioni |
| Invenomic Capital Management LP | $9.618.661 | 2.812.474 | 4,07% | Azioni |
| MARSHALL WACE, LLP | $8.832.423 | 2.582.579 | 3,73% | Azioni |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8.675.511 | 2.536.699 | 3,67% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.945.870 | 2.030.956 | 2,94% | Azioni |
| Dana Investment Advisors, Inc. | $6.650.556 | 1.944.607 | 2,81% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $6.408.062 | 1.873.127 | 2,71% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $5.609.358 | 1.640.163 | 2,37% | Azioni |
| STATE STREET CORP | $5.475.974 | 1.601.162 | 2,31% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $4.407.652 | 1.288.787 | 1,86% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $3.650.249 | 1.067.324 | 1,54% | Azioni |
| GOLDMAN SACHS GROUP INC | $2.923.176 | 854.730 | 1,24% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $2.457.441 | 718.550 | 1,04% | Azioni |
| NORTHERN TRUST CORP | $1.989.770 | 581.804 | 0,84% | Azioni |
| WOLVERINE ASSET MANAGEMENT LLC | $1.942.847 | 568.084 | 0,82% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $1.939.995 | 567.250 | 0,82% | Azioni |
| JANE STREET GROUP, LLC | $1.833.462 | 536.100 | 0,77% | Opzione Call |
| Vanguard Global Advisers, LLC | $1.742.463 | 509.492 | 0,74% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.665.913 | 487.109 | 0,70% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.575.252 | 460.600 | 0,67% | Opzione Call |
| TWO SIGMA ADVISERS, LP | $1.518.922 | 542.472 | 0,64% | Azioni |
| BW Gestao de Investimentos Ltda. | $1.446.971 | 423.091 | 0,61% | Azioni |
| CITADEL ADVISORS LLC | $1.321.919 | 386.526 | 0,56% | Azioni |
| CITADEL ADVISORS LLC | $1.191.528 | 348.400 | 0,50% | Opzione Call |
| Nebula Research & Development LLC | $1.115.105 | 122.539 | 0,47% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.109.492 | 324.413 | 0,47% | Azioni |
| MORGAN STANLEY | $1.052.342 | 307.701 | 0,44% | Azioni |
| Linden Thomas Advisory Services, LLC | $932.501 | 272.661 | 0,39% | Azioni |
| Bank of New York Mellon Corp | $917.257 | 268.204 | 0,39% | Azioni |
| Nuveen, LLC | $803.515 | 234.946 | 0,34% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $794.692 | 232.366 | 0,34% | Azioni |
| Kennondale Capital Management LLC | $772.544 | 225.890 | 0,33% | Azioni |
| STRS OHIO | $716.148 | 209.400 | 0,30% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $690.902 | 202.018 | 0,29% | Azioni |
| Cubist Systematic Strategies, LLC | $593.424 | 123.630 | 0,25% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $546.095 | 159.677 | 0,23% | Azioni |
| WELLS FARGO & COMPANY/MN | $542.754 | 158.700 | 0,23% | Azioni |
| XTX Topco Ltd | $503.725 | 147.288 | 0,21% | Azioni |
| ARISTEIA CAPITAL, L.L.C. | $447.391 | 130.816 | 0,19% | Azioni |
| Invesco Ltd. | $446.351 | 130.512 | 0,19% | Azioni |
| Man Group plc | $436.009 | 127.488 | 0,18% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $408.047 | 119.312 | 0,17% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $362.520 | 106.000 | 0,15% | Azioni |
| Allspring Global Investments Holdings, LLC | $356.879 | 99.687 | 0,15% | Azioni |
Proprietà ETF Posseduti da 18 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 426.785 SH | 19 Agosto 2026 | Giornaliero |
| QIDX · Spinnaker ETF Series | 0,11% | 14.310 NS | 31 Luglio 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 62.833 SH | 19 Agosto 2026 | Giornaliero |
| IWC · iShares Trust | 0,02% | 248.081 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 414.904 SH | 19 Agosto 2026 | Giornaliero |
| DFSV · Dimensional ETF Trust | 0,01% | 233.042 NS | 31 Luglio 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 34.414 NS | 31 Luglio 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 134.690 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.902.936 SH | 11 Settembre 2026 | Giornaliero |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 96.796 SH | 01 Ottobre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 29.296 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 105.616 SH | 08 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 19.827 SH | 03 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 833.270 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.185.973 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.453 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 184.892 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 666.394 SH | 11 Settembre 2026 | Giornaliero |
ACH Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
4 analisti · 2026-09-30Target medio $1.51 +199,4%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.